Contact this trialFirst, we need to learn more about you.
Immunomodulator
IMCY-0098 for Type 1 Diabetes
Recruiting0 awardsPhase 2
Boston, Massachusetts
This trial tests IMCY-0098, a new drug for type 1 diabetes. It aims to stop the immune system from attacking insulin-producing cells. The study will determine the best dose and ensure it is safe for patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service